Webinar. Risk Assessment Reusable Polyester and Single Use Tyvek IsoClean Cleanroom Garments Dupont

Size: px
Start display at page:

Download "Webinar. Risk Assessment Reusable Polyester and Single Use Tyvek IsoClean Cleanroom Garments Dupont"

Transcription

1 Webinar Risk Assessment Reusable Polyester and Single Use Tyvek IsoClean Cleanroom Garments Dupont 15 June 2018 GOP-Innovations your Partner for Practical Training and e-learning

2 Milenko Pavičić Pharmaceutical microbiologist, consultant, trainer, coach 10 years of research experience Vrije Universiteit Amsterdam (Medical and Oral Microbiology) Intervet International B.V. (Antibiotics R&D) 20 years of production and QC experience Pharmaceutical companies (NL, B, D, F) Hospital pharmacies (NL, B) Member of the NVZA (Dutch Society of Hospital Pharmacists) work group Microbiology and Hygiene Member of the User Committee of the NWO project Rapid Micro Statistics (TU/e, Prof. E. v/d Heuvel)

3 Pavičić Pharmaceutical Microbiology and GOP-Innovations Consultancy Courses Training Practical Training E-learning Microbiology, Aseptic production, Cleanrooms, Sterilisation, Cleaning, Disinfection, cgmp, Pharmacopoeias, Annex 1, QC, Validation, Qualification, Behavior, SOPs, Media fills, Environmental monitoring, Water systems, Sampling, Hygienic Design, Contamination Risk, Biosafety, Biosecurity

4 Subjects for today s webinar Quality Risk Management (QRM) Risk assessments Risk assessment reusable polyester and single use Tyvek IsoClean cleanroom garments Results and discussion Conclusions

5 New EU-GMP Annex 1 Processes, equipment, facilities and manufacturing activities should be managed in accordance with Quality Risk Management (QRM) principles that provide a proactive means of identifying, scientifically evaluating and controlling potential risks to quality.

6 Quality Risk Management (QRM) A systematic process for the assessment, control, communication, and review of risks to the quality of medicinal product across the product lifecycle.

7 Risk Assessment A systematic process of organizing information to support a risk decision to be made within a risk management process. It consists of the identification of hazards and the analysis and evaluation of risks associated with exposure to those hazards.

8 Harm, hazard, risk Harm: Health damage (illness, disability, death) Hazards: Medicines contaminated with micro-organisms, particles or fibers Risk: Probability of the occurence of harm and the severity of that harm

9 Cleanroom garments (1) GMP Contaminated garments may impact sterility of medicines, which is a Critical Quality Attribute Cleanroom garments form an important part of contamination control strategy

10 Cleanroom garments (2) GMP Garments shall protect the environment and medicines from contamination from people Garments shall be clean and shall not shed too many particles (qualified) and the release of fibers should be minimized (qualified) Garments shall be sterile (qualified) for grade A/B or shall have a very low (qualified) bioburden for grade C and D

11 Risk assessment cleanroom garment A risk assessment based on failure mode and effects analysis (FMEA) was executed Focus on relevant aspects of cleanroom garments that influence contamination of the garment and the cleanroom environment Comparison of reusable polyester and single use Tyvek IsoClean cleanroom garments

12 Explanation Risk Assessment qualitative risk component ranking Qualitative Ranking Risk Component Severity Occurrence Detection High Impact of the unwanted event* is severe Occurrence is often The failure will almost certainly escape detection Medium Impact of the unwanted event is moderate Occurrence is periodic Controls may detect the existence of a failure Low Impact of the unwanted event is low Occurrence is seldom The failure is obvious and readily detected *: The unwanted event is microbiological and/or particulate contamination of the gown and/or the environment leading to action limit excursions

13 Explanation Risk Assessment risk priority ranking (RPR) Detection Occurrence High Medium Low Low Medium High This cause is likely to occur, and when it does, it will be detected. Low or Medium Risk. This cause could occur, and if it did, it would be detected. Low or Medium Risk. This cause is not likely to occur, and if it does it will be detected. Low Risk. This cause is likely to occur, and the detection is not certain. High Risk. This cause could occur, and it could be detected. Medium or High Risk. This cause is not likely to occur, and if it did, it may be detected. Low or Medium Risk. This cause is likely to occur and is not likely to be detected. High Risk. This cause may occur, and it will not be detected. High Risk. This cause is not likely to occur, but if it did occur, it probably would not be detected. Medium or High Risk.

14 Risk assessment scope The influence of the different risk factors on the microbiological and particulate cleanliness of the garment itself and the working environment was evaluated Contamination with pyrogens and chemical contamination were not part of this risk assessment

15 FMEA failure (= unwanted event) Microbiological and/or particulate contamination of the gown and/or the environment leading to action limit excursions in the manufacturing cleanrooms where sterile medicines are produced, i.e. EU-GMP grade A/B and supporting C and D areas

16 FMEA impact of excursions of action limits Quality of the product or production environment is or may be at stake Action limit excursions in grade A/B may result in loss of sterility of the medicine or contamination of the medicine with an unacceptable amount of particles or fibers Severity is HIGH in case of loss of sterility

17 Risk assessment risk factors 1. Manufacturing of garment 2. Washing and sterilization 3. Garment repairs 4. Storage 5. Transport 6. Storage in warehouse 7. Transfer into cleanrooms 8. Storage in cleanroom 9. Gowning 10. Working 11. Ungowning

18 Risk assessment risk factors

19 Risk assessment risk factors

20 Risk assessment risk factors

21 Results (1)

22 Causes or process failures 1. manufacturing of the garment The risk for failure is lower for Tyvek IsoClean since the production of raw materials and garments is well controlled and done by the same manufacturer For reusable polyester garments this risk varies considerably

23 Causes or process failures 2. washing and sterilization and 3.repairs These risks are only applicable for reusable polyester garments and is not relevant for Tyvek IsoClean garments

24 Causes or process failures 4. storage in warehouse supplier The longer the storage the higher the risk for failures (damage, contamination)

25 Causes or process failures 5. transport The risk for failure is somewhat lower for Tyvek IsoClean garments because these are packed in a single-use sealed box. Most reusable garments are packed in a reusable crate with a closed lid. Packaging for DS products (Tyvek IsoClean Coverall)

26 Results (2)

27 Causes or process failures 6. storage in warehouse end-user The longer the storage the higher the risk for failures (damage, contamination)

28 Causes or process failures 7. transfer into cleanroom The risk for failure is somewhat lower for Tyvek IsoClean garments because of the package design, i.e. double sterile robust packaging which is then double clean packed. Packaging for DS products (Tyvek IsoClean Coverall)

29 Causes or process failures 8. storage in cleanroom The longer the storage the higher the risk for failures due to contaminated or damaged garment or packagings

30 Results (3)

31 Causes or process failures 9. gowning The risk for failures is mostly influenced by operator behavior, gowning method, gowning technique and the cleanliness of the environment

32 Causes or process failures 10. working (1) The risk for failures is lower for Tyvek IsoClean garments because the permeability of these garments is much lower compared to reusable garments. No risk for failures due to faulty repairs.

33 Causes or process failures 10. working (2) The quality of reusable garments will decline as a result of frequent washing and sterilization. This will lead to damage to the fabric and larger pores, thereby increasing the release of particles and fibers into the environment.

34 Causes or process failures 10. working (3) It is not known if there is a difference in pump effect between Tyvek IsoClean garments and reusable polyester garments. However, this phenomenon will play a role in contamination of the environment.

35 Causes or process failures 11. ungowning The degree of contamination of the environment is mostly influenced by the location and technique of ungowning.

36 Conclusions (1) The risk for microbiological or particulate contamination of the gown or the environment leading to action limit excursions is lower for Tyvek IsoClean garments compared to reusable polyester garments. The difference in pump effect between Tyvek IsoClean garments and reusable polyester garments should be investigated further.

37 Conclusions (2) The lower risk is mainly due to differences in the quality of raw materials and manufacturing, a closed and multiple clean and sterile packaging concept, better barrier properties (microorganisms and particles), and the single-use concept thereby eliminating the deteriorative effect of repeated use, washing and sterilization.

38 Additional applications for Tyvek IsoClean garment Tyvek IsoClean garment may also be a good candidate for people who work with cytotoxic substances, pathogenic microorganisms and viruses, other toxic substances.

Risk Based Environmental Monitoring

Risk Based Environmental Monitoring Risk Based Environmental Monitoring Presented by Tanja Varglien, August 2018 Slide 1 PharmOut 2018 Agenda Module 1 What is Environmental Monitoring Module 2 Regulatory requirements Module 3 Risk-based

More information

STERILITY TESTING OF PHARMACEUTICAL PRODUCTS

STERILITY TESTING OF PHARMACEUTICAL PRODUCTS STERILITY TESTING OF PHARMACEUTICAL PRODUCTS Tim Sandle CONTENTS Introduction xiii 1 STERILITY 1 Introduction 1 Sterility 3 Microorganisms and Microbial Growth 5 Types of microorganisms 7 Sterilization

More information

Overview Internal review

Overview Internal review Overview Internal review Presentation title: QRM, It s not all about the assessment Track title: Day 1, Session 2 Speaker: Seamus Orr Date / Time: 10 August 2015, 14.30 15.00 Time allotted: 30 minutes

More information

Environmental Monitoring How to Satisfy the Regulator. Presented by Tanja Varglien, July 2017

Environmental Monitoring How to Satisfy the Regulator. Presented by Tanja Varglien, July 2017 Environmental Monitoring How to Satisfy the Regulator Presented by Tanja Varglien, July 2017 Slide 1 PharmOut 2017 Using Glisser You will be able to tap the download link at the end of each presentation.

More information

DuPont Tyvek IsoClean, Model IC 458 B WH MS

DuPont Tyvek IsoClean, Model IC 458 B WH MS Technical data sheet DuPont Tyvek IsoClean, Model IC 458 B WH MS CAT I Option MS SAL Product Description DuPont Tyvek IsoClean boot cover model IC 458 B WH MS. Tunnelled elastication at shin. Ties. Elasticated

More information

Excipient Risk Assessment

Excipient Risk Assessment Excipient Risk Assessment Richard O Sullivan- GMP Inspector GMP Conference 7 February 2017 Dublin Content Background 1 Guidance 2 HPRA Expectations 3 07/02/2017 2 Excipient Risk Assessment-Why? 07/02/2017

More information

Town and Country Compounding and Consultation Services, LLC 10/17/17

Town and Country Compounding and Consultation Services, LLC 10/17/17 Town and Country Compounding and Consultation Services, LLC 10/17/17 Division of Pharmaceutical Quality Operations I 10 Waterview Blvd, 3rd FL Parsippany, NJ 07054 Telephone: (973) 331-4900 FAX: (973)

More information

Latest range of highest quality sterile and filtered cleanroom alcohols

Latest range of highest quality sterile and filtered cleanroom alcohols Latest range of highest quality sterile and filtered cleanroom alcohols Shield Medicare Company Profile Shield Medicare is a market leader in the supply of specialist contamination control products to

More information

Single market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations

Single market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals : regulatory framework and market authorisations Brussels,

More information

DuPont Tyvek IsoClean, Model IC 458 B WH 0B

DuPont Tyvek IsoClean, Model IC 458 B WH 0B Technical data sheet DuPont Tyvek IsoClean, Model IC 458 B WH 0B CAT I Product Description DuPont Tyvek IsoClean slip-retardant boot cover model IC 458 B WH 0B. Tunnelled elastication at shin. Ties. Elasticated

More information

Medidée Services SA. Nano-Tera.ch. 05 February 2015 part 4. Intro ISO GMP - GLP Pierre-Alain Sommer

Medidée Services SA. Nano-Tera.ch. 05 February 2015 part 4. Intro ISO GMP - GLP Pierre-Alain Sommer Nano-Tera.ch 05 February 2015 part 4 Intro ISO GMP - GLP Pierre-Alain Sommer Pierre-alain.sommer@medidee.com www.medidee.com Nano-Tera 2015 05.02.2015 Introduction to ISO 13485, cgmp s and GLP s Context

More information

Final Rule for Preventive Controls for Animal Food

Final Rule for Preventive Controls for Animal Food Final Rule for Preventive Controls for Animal Food http://www.fda.gov/fsma THE FUTURE IS NOW 1 Background Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Food

More information

How Do You Know If Your Sterilized Instruments Remain Sterile?

How Do You Know If Your Sterilized Instruments Remain Sterile? How Do You Know If Your Sterilized Instruments Remain Sterile? Disclosure Harry Shaffer is the first author of the sterility maintenance study covered in this presentation and has been compensated by Halyard

More information

Workshop on the reprocessing of medical devices. 5. December Brussels. Nikou Ghassemieh Managing Director

Workshop on the reprocessing of medical devices. 5. December Brussels. Nikou Ghassemieh Managing Director Workshop on the reprocessing of medical devices 5. December 2008 - Brussels Nikou Ghassemieh Managing Director Established: 2003 Members from science, industry and medical practice Tasks and Goals: - Increasing

More information

Healthcare Sterilisation: Challenging Practices Volume 2

Healthcare Sterilisation: Challenging Practices Volume 2 Contents 1 Traditional Chemical Sterilisation Methods... 1 1.1 Ethylene Oxide Sterilisation... 3 1.1.1 Green sterilisation (Benefits versus Risks)... 4 1.1.2 Ethylene Oxide Residuals... 8 1.1.3 Advantages

More information

Peninsula Dental Social Enterprise (PDSE)

Peninsula Dental Social Enterprise (PDSE) Peninsula Dental Social Enterprise (PDSE) Decontamination - Cleaning and Disinfection Version 3.0 Date approved: November 2016 Approved by: The Board Review due: November 2019 Policy will be updated as

More information

Healthcare Sterilisation: Introduction and Standard Practices, Volume 1

Healthcare Sterilisation: Introduction and Standard Practices, Volume 1 Contents 1. Overview of Sterilisation and Background... 1 1.1 Magic Wand... 1 1.1.1 Definition of Sterilisation... 2 1.1.2 Detectives or Forensic Scientists... 3 1.1.3 Idealised Process... 6 1.1.4 Lesser

More information

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard GB15980-1995 Translated by: www.chinesestandard.net Email: Sales@ChineseStandard.net ICS 11.120.20 C 59 National Standard of the People s Republic of China GB Hygienic

More information

IPEC Europe Suggested Alternative (if none then original text is clear and needs no alteration) Purpose and Scope

IPEC Europe Suggested Alternative (if none then original text is clear and needs no alteration) Purpose and Scope IPEC Europe Observations and Recommendations on Guidelines On The Formalised Risk Assessment For Ascertaining The Appropriate Good Manufacturing Practice For Excipients Of Medicinal Products For Human

More information

The Science of Personal and Process Protection. KIMTECH* PPE Range for Pharmaceutical Industries

The Science of Personal and Process Protection. KIMTECH* PPE Range for Pharmaceutical Industries The Science of Personal and Process Protection KIMTECH* PPE Range for Pharmaceutical Industries Your Challenges Pharmaceutical companies face some of the toughest challenges in modern day business. The

More information

How Do You Know If a Sterilized Package Remains Sterile?

How Do You Know If a Sterilized Package Remains Sterile? How Do You Know If a Sterilized Package Remains Sterile? 1 Acknowledgments Bioaerosol and Applied Microbiology Team Brian Heimbuch, MS Group Lead Del Harnish, MS Lead Technical Mike McDonald, MS Lead Engineer

More information

A WHITE PAPER STERILITY TESTING ESSENTIAL THINGS YOU MUST KNOW

A WHITE PAPER STERILITY TESTING ESSENTIAL THINGS YOU MUST KNOW A WHITE PAPER STERILITY TESTING ESSENTIAL THINGS YOU MUST KNOW By Steven G. Richter, Ph.D 1. A WHITE PAPER STERILITY TESTING ESSENTIAL THINGS YOU MUST KNOW (includes combination products) Steven G. Richter

More information

A high-level overview of the requirements of medical packaging standards

A high-level overview of the requirements of medical packaging standards Medical Packaging A high-level overview of the requirements of medical packaging standards Dec 2012 Thierry Wagner Regulatory Affairs Director Europe, Middle East and Africa DuPont Medical & Pharmaceutical

More information

EU Regulatory Update & GMP Deficiencies. Bryan J Wright July 2017

EU Regulatory Update & GMP Deficiencies. Bryan J Wright July 2017 EU Regulatory Update & GMP Deficiencies Bryan J Wright July 2017 Slide 1 PharmOut 2017 Outline Update on changes in EU GMP Guide Summary of GMP changes to the Guide Important details of changes over the

More information

Cleanroom vs. Isolator Concept Performance and cost comparison. Guy Turner, General Manager Bioquell Asia Pacific

Cleanroom vs. Isolator Concept Performance and cost comparison. Guy Turner, General Manager Bioquell Asia Pacific Cleanroom vs. Isolator Concept Performance and cost comparison Guy Turner, General Manager Bioquell Asia Pacific guy.turner@bioquell.com Slide 1 PharmOut 2017 Requirements for Sterility Testing Environment

More information

2013 USP Chapter <797> Compliance Survey & Current Practice Standards

2013 USP Chapter <797> Compliance Survey & Current Practice Standards 2013 USP Chapter Compliance Survey & Current Practice Standards Kenneth S. Latta, BS, RPh Gates Healthcare Associates, Inc Hillsborough, NC We Welcome Your Questions You can submit questions throughout

More information

Cross Contamination & the EU GMP Guide. Bryan J Wright July 2017

Cross Contamination & the EU GMP Guide. Bryan J Wright July 2017 Cross Contamination & the EU GMP Guide Bryan J Wright July 2017 Slide 1 PharmOut 2017 Outline PICs GMP (v13) and Cross Contamination (CC) EU GMP Guide changes to Chapters 3 & 5 Other related EU regulatory

More information

SCAN RDI PROTOCOLS FOR ENVIRONMENTAL MONITORING

SCAN RDI PROTOCOLS FOR ENVIRONMENTAL MONITORING SCAN RDI PROTOCOLS FOR ENVIRONMENTAL MONITORING Menu Surface monitoring using ChemSwab Air Monitoring using Coriolis µ Bioburden in raw materials and intermediates 2 Menu Surface monitoring using ChemSwab

More information

Managing Allergens within a manufacturing context. Helen Brown CampdenBRI Chipping Campden

Managing Allergens within a manufacturing context. Helen Brown CampdenBRI Chipping Campden Managing Allergens within a manufacturing context Helen Brown CampdenBRI Chipping Campden Food Allergens An unusual food safety issue Harmless natural substances however In allergic individuals cause reactions,

More information

Talon Compounding Pharmacy 10/3/17

Talon Compounding Pharmacy 10/3/17 Talon Compounding Pharmacy 10/3/17 Office of Pharmaceutical Quality Operations, Division II 4040 N. Central Expressway, Suite 300 Dallas, Texas 75204 October 3, 2017 CMS Case # 522630 VIA UPS EXPRESS WARNING

More information

Provläsningsexemplar / Preview. First edition

Provläsningsexemplar / Preview. First edition Provläsningsexemplar / Preview TECHNICAL SPECIFICATION ISO/TS 19930 First edition 2017-12 Guidance on aspects of a risk-based approach to assuring sterility of terminally sterilized, single-use health

More information

cgmp (21 CFR 111) Regulation and Compliance Overview

cgmp (21 CFR 111) Regulation and Compliance Overview cgmp (21 CFR 111) Regulation and Compliance Overview Neogen Effective Compliance Seminar September 23, 2014 Michael McGuffin President, American Herbal Products Association mmcguffin@ahpa.org Regulation

More information

Overview of Dietary Supplement GMP Inspection Trends Quality Session 6

Overview of Dietary Supplement GMP Inspection Trends Quality Session 6 Overview of Dietary Supplement GMP Inspection Trends Quality Session 6 Presented by: Dean R. Cirotta, MBA President & Chief Operating Officer EAS Consulting Group, LLC 1700 Diagonal Road, Suite 750 Alexandria,

More information

Why Bio Security is Essential in the Ornamental Fish Industry, and How to Implement it Danny Benjamin Hazorea Aquatics Kibbutz Hazorea, Israel

Why Bio Security is Essential in the Ornamental Fish Industry, and How to Implement it Danny Benjamin Hazorea Aquatics Kibbutz Hazorea, Israel Why Bio Security is Essential in the Ornamental Fish Industry, and How to Implement it Danny Benjamin Hazorea Aquatics Kibbutz Hazorea, Israel 2 nd International Ornamental Fish Trade and Technical Conference

More information

Effective Airflow Visualization Studies. Gordon Farquharson, July 2017

Effective Airflow Visualization Studies. Gordon Farquharson, July 2017 Effective Airflow Visualization Studies Gordon Farquharson, July 2017 Slide 1 PharmOut 2017 Agenda Regulatory imperative Role of CFD Air velocity measurements Airflow visualisation to prove effectiveness

More information

VOCATIONAL EDUCATION AND TRAINING STANDARD FOR A PHARMACIST S ASSISTANT

VOCATIONAL EDUCATION AND TRAINING STANDARD FOR A PHARMACIST S ASSISTANT THE REPUBLIC OF LITHUANIA MINISTRY OF EDUCATION AND SCIENCE MINISTRY OF SOCIAL SECURITY AND LABOUR VOCATIONAL EDUCATION AND TRAINING STANDARD FOR A PHARMACIST S ASSISTANT Vocational education level 5 Vilnius,

More information

Potential Hazards in Food; Ensuring the Concept of Tayyab in Food. Mian N. Riaz, Ph.D

Potential Hazards in Food; Ensuring the Concept of Tayyab in Food. Mian N. Riaz, Ph.D Potential Hazards in Food; Ensuring the Concept of Tayyab in Food Mian N. Riaz, Ph.D Director - Food Protein R & D Center; Texas A&M University, Texas, USA E-mail: mnriaz@tamu.edu Abstract: Halal means

More information

July 27-30, th Annual Meeting of the Poultry Science Association Louisville, Kentucky. Presented at:

July 27-30, th Annual Meeting of the Poultry Science Association Louisville, Kentucky. Presented at: July 27-30, 2015 104 th Annual Meeting of the Poultry Science Association Louisville, Kentucky Presented at: From Egg to Plate The Influence of Gut Health Symposium Presentations distributed by DuPont

More information

PRE-STERILIZED SPINE IMPLANTS

PRE-STERILIZED SPINE IMPLANTS PRE-STERILIZED SPINE IMPLANTS Surgical Technical Technique Report Hip Knee Spine Navigation PRE-STERILIZED SPINE IMPLANTS Technical Report Hip Knee Spine Navigation 1PRE-STERILIZED INTRODUCTION SPINE IMPLANTS

More information

PIC/S GUIDANCE ON CLASSIFICATION OF GMP DEFICIENCIES

PIC/S GUIDANCE ON CLASSIFICATION OF GMP DEFICIENCIES PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 040-1 3 Appendices 1 January 2019 PIC/S GUIDANCE ON CLASSIFICATION OF GMP DEFICIENCIES PIC/S January 2019 Reproduction

More information

Good Cleanroom Design & Construction Practice. Presented by Gordon Farquharson July 2017

Good Cleanroom Design & Construction Practice. Presented by Gordon Farquharson July 2017 Good Cleanroom Design & Construction Practice Presented by Gordon Farquharson July 2017 Slide 1 PharmOut 2017 Agenda Good Design & Construction Practice Cleanrooms Based on the scope and intents of the

More information

Supporting positive clinical outcomes. Hospital and patient care product offering

Supporting positive clinical outcomes. Hospital and patient care product offering healthcare Supporting positive clinical outcomes Hospital and patient care product offering Positively impacting the health of your patients and your organisation Thermo Fisher Scientifi c s extensive

More information

Deviations Inspection Observations & Issues to Consider for Achieving Compliance

Deviations Inspection Observations & Issues to Consider for Achieving Compliance Deviations Inspection Observations & Issues to Consider for Achieving Compliance Kevin O Donnell, Ph.D. Market Compliance Manager Irish Medicines Board IMB GMP & Market Compliance Information Day Dublin,

More information

Chapter 13. Preventing Infection. Copyright 2019 by Elsevier, Inc. All rights reserved.

Chapter 13. Preventing Infection. Copyright 2019 by Elsevier, Inc. All rights reserved. Chapter 13 Preventing Infection Copyright 2019 by Elsevier, Inc. All rights reserved. Lesson 13.1 Define the key terms and key abbreviations in this chapter. Identify what microbes need to live and grow.

More information

FORTIFICATION OF MILLED MAIZE PRODUCTS

FORTIFICATION OF MILLED MAIZE PRODUCTS What is food fortification? Why is it important to fortify? Fortification is the strengthening of food with the addition of essential micro-nutrients (vitamins and minerals). Essential micro-nutrients

More information

Stonegate Pharmacy LP 11/10/16

Stonegate Pharmacy LP 11/10/16 Stonegate Pharmacy LP 11/10/16 November 10, 2016 2017 DAL WL 03 WARNING LETTER UPS Overnight Rene F. Garza, Pharm.D., Chief Executive Officer Stonegate Pharmacy, LP 2501 W. William Cannon Drive, Suite

More information

PDA Points to Consider relating to EU GMP Annex 1 changes. Presented by Ashley Isbel 30 November, 2016

PDA Points to Consider relating to EU GMP Annex 1 changes. Presented by Ashley Isbel 30 November, 2016 PDA Points to Consider relating to EU GMP Annex 1 changes Presented by Ashley Isbel 30 November, 2016 Lets get interactive! On your smart device, open a browser app and go to the link provided Click on

More information

Harvard University Exposure Control Plan

Harvard University Exposure Control Plan Harvard University Exposure Control Plan Harvard University is committed to providing a safe and healthy work environment. In accordance with this goal, the Occupational Health and Safety Administration

More information

Biosecurity and biosafety in the laboratory: Experience of the OIE Reference Laboratory for Avian Influenza

Biosecurity and biosafety in the laboratory: Experience of the OIE Reference Laboratory for Avian Influenza Biosecurity and biosafety in the laboratory: Experience of the OIE Reference Laboratory for Avian Influenza Isabella Monne (DVM, PhD) National OIE/FAO Reference Laboratory for Newcastle Disease and Avian

More information

The Mechanics of the Dental Anesthetic Cartridge

The Mechanics of the Dental Anesthetic Cartridge The Mechanics of the Dental Anesthetic Cartridge Sponsored by Pierrel, makers of Orabloc (Articaine hydrochloridre 40mg/ml and epinephrine Injection) Abstract Local anesthesia is the fundamental part of

More information

Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT of the Vaccine manufacturer. Hualan Biological Bacterin Co.

Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT of the Vaccine manufacturer. Hualan Biological Bacterin Co. Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT of the Vaccine manufacturer Part 1 Manufacturers details Company information Name of manufacturer Corporate address of manufacturer

More information

Environmental Monitoring in the Cell Processing Laboratory What to do with the data?

Environmental Monitoring in the Cell Processing Laboratory What to do with the data? Environmental Monitoring in the Cell Processing Laboratory What to do with the data? Shelly Heimfeld, Ph.D. Fred Hutchinson Cancer Research Center Seattle Cancer Care Alliance ISCT President Somatic Cell

More information

AMENDATORY SECTION (Amending WSR , filed 10/10/95, effective 11/10/95)

AMENDATORY SECTION (Amending WSR , filed 10/10/95, effective 11/10/95) AMENDATORY SECTION (Amending WSR 95-21-041, filed 10/10/95, effective 11/10/95) WAC 246-817-601 Purpose. The purpose of WAC 246-817-601 through ((246-817-630)) 246-817-660 is to establish requirements

More information

Table 1 Model of STRIDESMOOTH (Stride) and STRIDESMOOTH+ Microcatheter

Table 1 Model of STRIDESMOOTH (Stride) and STRIDESMOOTH+ Microcatheter AMM-Q269 Ver.7 Page 2 of 5 Table 1 Model of STRIDESMOOTH (Stride) and STRIDESMOOTH+ Microcatheter Product name STRIDESMOOTH (Stride) Model No. STD105-22S STD125-22S STD125-22A STD130-22S STD150-22S STD105-26S

More information

Prepare and maintain environment, instruments, and equipment for clinical dental procedures

Prepare and maintain environment, instruments, and equipment for clinical dental procedures Level: 2 Credit value: 2 NDAQ number: F/502/7346 Unit aim This unit focuses on infectious diseases and their routes of transmission. It concentrates on the methods of infection control and applying appropriate

More information

SAFE HANDLING OF ONCOLOGY DRUGS

SAFE HANDLING OF ONCOLOGY DRUGS SAFE HANDLING OF ONCOLOGY DRUGS TM Every year brings new hope and improves the outlook for patients with cancer. Advancements in biology, patient care and new treatments are key drivers to fight the battle

More information

AKA Good Manufacturing Practice (GMP) Certification Program

AKA Good Manufacturing Practice (GMP) Certification Program AKA Good Manufacturing Practice (GMP) Certification Program Preamble The American Kratom Association (AKA) is establishing this program to assure the safety and integrity of kratom dietary supplements

More information

Validation Introduction. Presented by John Montalto 27 March, 2013

Validation Introduction. Presented by John Montalto 27 March, 2013 Validation Introduction Presented by John Montalto 27 March, 2013 John Montalto Bachelor of Science Management Diploma >15 years of Industry Experience Consultant to United Nations various Government Regulatory

More information

2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts

2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts 2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts 116 USP Update 2008 and Personnel-Related Environmental Sampling Trissel, L.A. TriPharma Research, P.O. Box 265, Cashiers,

More information

247 CMR BOARD OF REGISTRATION IN PHARMACY

247 CMR BOARD OF REGISTRATION IN PHARMACY 247 CMR 18.00: NON-STERILE COMPOUNDING Section 18.01: Authority and Purpose 18.02: Non-Sterile Compounding Process 18.03: Non-Sterile Compounding Facility 18.04: Non-Sterile Compounding Equipment 18.05:

More information

Sustainable cleaning of the health care environment.

Sustainable cleaning of the health care environment. Sustainable cleaning of the health care environment. Has the current practice of cleaning the health care environment relying on the use of disinfectants and their label claims and instructions for use

More information

Chapter 12. Preventing Infection. Elsevier items and derived items 2014, 2010 by Mosby, an imprint of Elsevier Inc. All rights reserved.

Chapter 12. Preventing Infection. Elsevier items and derived items 2014, 2010 by Mosby, an imprint of Elsevier Inc. All rights reserved. Chapter 12 Preventing Infection Infection Infection is a major safety and health hazard. The health team follows certain practices and procedures to protect patients, residents, visitors, and staff from

More information

Latex and Occupational Dermatitis Policy Incorporating Glove Selection

Latex and Occupational Dermatitis Policy Incorporating Glove Selection Latex and Occupational Dermatitis Policy Incorporating Glove Selection DOCUMENT CONTROL: Version: 3 Ratified by: Risk Management Sub Group Date ratified: 17 July 2013 Name of originator/author: Health

More information

Healthcare Solutions. Hand Hygiene and Surface Disinfection

Healthcare Solutions. Hand Hygiene and Surface Disinfection Healthcare Solutions Hand Hygiene and Surface Disinfection Understanding your needs Dedicated to healthcare At KIMBERLY-CLARK PROFESSIONAL* we have a long history of helping healthcare staff perform their

More information

The Food and Drug Administration (FDA) is providing a detailed list of supplemental duodenoscope reprocessing measures that emerged from an agency-led

The Food and Drug Administration (FDA) is providing a detailed list of supplemental duodenoscope reprocessing measures that emerged from an agency-led The Food and Drug Administration (FDA) is providing a detailed list of supplemental duodenoscope reprocessing measures that emerged from an agency-led expert panel meeting earlier this year. Hospitals

More information

Animal health requirements for heat-processed poultry meat and meat products. to be exported from Russian Federation to Japan.

Animal health requirements for heat-processed poultry meat and meat products. to be exported from Russian Federation to Japan. Animal health requirements for heat-processed poultry meat Animal health requirements for heat-processed poultry meat and meat products to be exported from Russian Federation to 1. This document defines

More information

Chapter 11 PREVENTING INFECTION. Elsevier items and derived items 2010 by Mosby, Inc. an affiliate of Elsevier Inc. All rights reserved

Chapter 11 PREVENTING INFECTION. Elsevier items and derived items 2010 by Mosby, Inc. an affiliate of Elsevier Inc. All rights reserved Chapter 11 PREVENTING INFECTION Infection is a major safety and health hazard. The health team follows certain practices and procedures to protect patients, residents, visitors, and staff from infection.

More information

SECTION 13.0 SPECIMENS FOR LABORATORY EXAMINATION

SECTION 13.0 SPECIMENS FOR LABORATORY EXAMINATION SECTION 13.0 SPECIMENS FOR LABORATORY EXAMINATION Introduction Collection of Specimens for Microbiological Examination: Safe Handling of Specimens Packaging & Transportation of Specimens Specimen Rejection

More information

Facility and Management

Facility and Management Training Course of Microbial Resources Information Management and Utilization for Developing Countries BSL-3 Laboratory Facility and Management Dr. Yiping Zhu Sep. 14 2016 Pathogens and BSL-3 laboratory

More information

Respiratory Protection for Exposures to the Influenza A (H1N1) Virus. Frequently Asked Questions (FAQs)

Respiratory Protection for Exposures to the Influenza A (H1N1) Virus. Frequently Asked Questions (FAQs) 3M Occupational Health and 3M Center Environmental Safety Division St. Paul, MN 55144-1000 651 733 1110 Respiratory Protection for Exposures to the Influenza A (H1N1) Virus Frequently Asked Questions (FAQs)

More information

Guidance for Reduced Oxygen Packaging

Guidance for Reduced Oxygen Packaging Consumer Protection Division Policy, Standards, And Quality Assurance Section Public Sanitation And Retail Food Safety Unit INTRODUCTION Guidance for Reduced Oxygen Packaging While reduced oxygen packaging

More information

Quality Assurance and Control

Quality Assurance and Control Quality Assurance and Control CHAPTER 51 John H Parker, PhD John E Enders, PhD, MBA The pharmaceutical industry, as a vital segment of the healthcare system, conducts research and manufactures and markets

More information

Wipe Kit. For addressing <USP 800> Hazardous Drugs - Handling in Healthcare Settings

Wipe Kit. For addressing <USP 800> Hazardous Drugs - Handling in Healthcare Settings Wipe Kit For addressing Hazardous Drugs - Handling in Healthcare Settings WipeDown 1-2-3 Technical Data File Page 2 of 10 Product Overview VAI s WipeDown 1-2-3 was designed to address the risk

More information

Respiratory Protection for Exposures to the Swine Influenza A (H1N1) Virus: Health Care Workers

Respiratory Protection for Exposures to the Swine Influenza A (H1N1) Virus: Health Care Workers 3M Canada Company P. O. Box / C.P. 5757 Compagnie 3M Canada London, Ontario N6A 4T1 3 April 29, 2009 Respiratory Protection for Exposures to the Swine Influenza A (H1N1) Virus: Health Care Workers Frequently

More information

BLOODBORNE PATHOGENS EXPOSURE CONTROL PLAN. Prepared By: Triumvirate Environmental

BLOODBORNE PATHOGENS EXPOSURE CONTROL PLAN. Prepared By: Triumvirate Environmental BLOODBORNE PATHOGENS EXPOSURE CONTROL PLAN Prepared By: Triumvirate Environmental Developed: October 2010 Reviewed and Updated: October 2011 Table of Contents 1.0 General Policy... 4 1.1 Purpose... 4 1.2

More information

Committed to Environment, Health and Safety

Committed to Environment, Health and Safety Committed to Environment, Health and Safety Environment, Health and Safety Management System and Policy of GCP Applied Technologies Inc. SEPTEMBER 1, 2017 The GCP Environment, Health, and Safety Management

More information

Sterilization of health care products Radiation. Part 2: Establishing the sterilization dose

Sterilization of health care products Radiation. Part 2: Establishing the sterilization dose Provläsningsexemplar / Preview INTERNATIONAL STANDARD ISO 11137-2 Third edition 2013-06-01 Sterilization of health care products Radiation Part 2: Establishing the sterilization dose Stérilisation des

More information

Clostridium difficile Essential information

Clostridium difficile Essential information Clostridium difficile Essential information Clostridium difficile Origins Clostridium difficile (C. diff) is a Gram positive, spore forming, anaerobic bacterium with a rod structure. It was first identified

More information

Biosafety & Biosecurity in the Laboratory. Based on the OIE Terrestrial Manual for Diagnostic Tests and Vaccines

Biosafety & Biosecurity in the Laboratory. Based on the OIE Terrestrial Manual for Diagnostic Tests and Vaccines Biosafety & Biosecurity in the Laboratory Based on the OIE Terrestrial Manual for Diagnostic Tests and Vaccines Keeping people and animals safe Keeping samples safe Definitions Biosafety: The measures

More information

THE NON PENICILLIN BETA LACTAM DRUG CROSS CONTAMINATION PREVENTION; USFDA PERSPECTIVE

THE NON PENICILLIN BETA LACTAM DRUG CROSS CONTAMINATION PREVENTION; USFDA PERSPECTIVE THE NON PENICILLIN BETA LACTAM DRUG CROSS CONTAMINATION PREVENTION; USFDA PERSPECTIVE An overview by Sarah Vugigi, M. Pharm, Elys Chemical Industries Ltd, Nairobi, Kenya INTRODUCTION This guidance describes

More information

INFECTION CONTROL IN PRACTICE. Continuing Education

INFECTION CONTROL IN PRACTICE. Continuing Education INFECTION CONTROL IN PRACTICE Continuing Education CONTINUING EDUCATION: INFECTION CONTROL IN PRACTICE DESCRIPTION This seminar introduces infection control principals and best practices pertaining to

More information

ISO 13485:2016 Medical Devices Training Handbook

ISO 13485:2016 Medical Devices Training Handbook ISO 13485:2016 Medical Devices Training Handbook Presented By Maria Mylonas Page 1 of 16 pages How to use this handbook The handbook is organized to focus on particular skills and revisions. These lessons

More information

Defining, achieving, and demonstrating effective performance of containment systems. Gordon Farquharson, July 2017

Defining, achieving, and demonstrating effective performance of containment systems. Gordon Farquharson, July 2017 Defining, achieving, and demonstrating effective performance of containment systems Gordon Farquharson, July 2017 Slide 1 PharmOut 2017 Agenda Objectives and Principles. A hierarchy of containment techniques.

More information

Food Allergen Environmental Monitoring Guide

Food Allergen Environmental Monitoring Guide Food Allergen Environmental Monitoring Guide A EUROFINS WHITE PAPER OCTOBER 2012 This document by Eurofins is licensed under a Creative Commons Attribution 3.0 Unported License. A COMPREHENSIVE GUIDE TO

More information

This whitepaper will cover the suggested methodology to be employed when developing a PCP plan. This includes how to develop your plan in accordance

This whitepaper will cover the suggested methodology to be employed when developing a PCP plan. This includes how to develop your plan in accordance This whitepaper will cover the suggested methodology to be employed when developing a PCP plan. This includes how to develop your plan in accordance with FSMA s Final Rule for Preventive Controls for Human

More information

Recommendations for cleaning, disinfection and sterilization of orthopaedic instruments and devices from Swemac.

Recommendations for cleaning, disinfection and sterilization of orthopaedic instruments and devices from Swemac. Recommendations for cleaning, disinfection and sterilization of orthopaedic instruments and devices from Swemac. This document is intended as guidance for decontamination and sterilization for medical

More information

Outbreak of Bacillus cereus in a burn unit

Outbreak of Bacillus cereus in a burn unit Outbreak of Bacillus cereus in a burn unit Annette Schuermans Katholieke Universiteit Leuven/ University Hospitals Leuven October 14 th 2010 UZ Leuven 1 3 1 2 2 1, 22, 22% TBSA due to a car accident 2,

More information

SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS

SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS Manufacturing specialized products in a pharmaceutical

More information

LEARNING MODULE: INFECTION CONTROL BLOODBORNE PATHOGENS ISOLATION PRECAUTIONS PHARMACEUTICAL WASTE

LEARNING MODULE: INFECTION CONTROL BLOODBORNE PATHOGENS ISOLATION PRECAUTIONS PHARMACEUTICAL WASTE LEARNING MODULE: INFECTION CONTROL BLOODBORNE PATHOGENS ISOLATION PRECAUTIONS PHARMACEUTICAL WASTE For Residents & Instructors ggbha.org Updated 6/18/2018 This learning module must be reviewed by residents

More information

VIOLATIONS AND POTENTIAL SOLUTIONS

VIOLATIONS AND POTENTIAL SOLUTIONS VIOLATIONS AND POTENTIAL SOLUTIONS Food Safety Forum Tuesday, July 17, 2018 FOODBORNE ILLNESS RISK FACTORS While the food supply in the United States is one of the safest in the world, the Centers for

More information

Guidance for the Control of Animal Allergens

Guidance for the Control of Animal Allergens Environmental & Occupational Health Guidance for the Control of Animal Allergens I. Background Laboratory animal allergy (LAA) is an occupationally acquired condition that affects up to 1/3 of laboratory

More information

APPLIED EDUCATIONAL SYSTEMS. Infection Control. Health Science and Technology Education. Table of Contents

APPLIED EDUCATIONAL SYSTEMS. Infection Control. Health Science and Technology Education. Table of Contents Infection Control and Technology Education Microorganisms Microorganisms are small living bodies that are not visible to the naked eye. Nonpathogens - maintain body processes Pathogens cause infection

More information

The term Routine Practices is used to describe practices that were previously known as Universal Precautions.

The term Routine Practices is used to describe practices that were previously known as Universal Precautions. Health & Safety Manual Health Promotion & Wellness ROUTINE PRACTICES PROCEDURES INTRODUCTION The term Routine Practices is used to describe practices that were previously known as Universal Precautions.

More information

San Diego Compounding Pharmacy 9/25/17

San Diego Compounding Pharmacy 9/25/17 San Diego Compounding Pharmacy 9/25/17 Division of Pharmaceutical Quality Operations IV 19701 Fairchild Road Los Angeles, CA 92612 WARNING LETTER VIA UNITED PARCEL SERVICE SIGNATURE REQUIRED September

More information

040716_ANDI_VENTIS WEBSITE(new) Printout 1. HOME PAGE. Welcome to our world of Dry Powder Inhalers!

040716_ANDI_VENTIS WEBSITE(new) Printout 1. HOME PAGE. Welcome to our world of Dry Powder Inhalers! 1. HOME PAGE Welcome to our world of Dry Powder Inhalers! Andi-Ventis Ltd, established in 2001 is a joint venture between Medochemie Ltd, Cyprus and Miat SpA Italy, founded to carry out the pharmaceutical

More information

GUIDE TO REGISTER HOMEOPATHIC PRODUCTS FOR VETERINARY USE

GUIDE TO REGISTER HOMEOPATHIC PRODUCTS FOR VETERINARY USE CAMEVET PROCEEDINGS II REVIEW DATE in BRAZIL: HOMEOPATHIC COMMISSION - SINDAN August 18, 2016 GUIDE TO REGISTER HOMEOPATHIC PRODUCTS FOR VETERINARY USE SÃO PAULO, BRAZIL August 2016 Page 2 of 9 GUIDE TO

More information

Questions and Answers on Candidates for Substitution

Questions and Answers on Candidates for Substitution Questions and Answers on Candidates for Substitution Rev. 1, January 2015 Background The European Commission is required by Regulation (EC) No 1107/2009 ( the Regulation ) to establish a list of substances

More information

Intrathecal. By the end of this chapter, you will be able to: Introduction. Chapter 20

Intrathecal. By the end of this chapter, you will be able to: Introduction. Chapter 20 Chapter 20 Intrathecal Preparations By the end of this chapter, you will be able to: l Describe the specific risks with intrathecal cytotoxic products l List five checks that need to be carried out on

More information

LANACM13 Plan, manage and evaluate site hygiene and biosecurity

LANACM13 Plan, manage and evaluate site hygiene and biosecurity Plan, manage and evaluate site hygiene and biosecurity Overview This standard describes the process of planning, managing and evaluating the procedures and protocols developed and put in place for site

More information

FMEA AND RPN NUMBERS. Failure Mode Severity Occurrence Detection RPN A B

FMEA AND RPN NUMBERS. Failure Mode Severity Occurrence Detection RPN A B FMEA AND RPN NUMBERS An important part of risk is to remember that risk is a vector: one aspect of risk is the severity of the effect of the event and the other aspect is the probability or frequency of

More information